EMA approves use of Novavax in people 18 years and older

Name: EMA approves use of Novavax in people 18 years and older
Uploaded: 2021-12-21T15:39:15+03:00
Duration: 1 min 23 s
Description: EMA approves use of Novavax in people 18 years and older

The European Union has approved the "Novavax" vaccine as it battles to fend off a potentially more dangerous fifth covid-19 wave fueled by the new Omicron variant.